This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco.

San Francisco, October 2025: The opening session of Transcatheter Cardiovascular Therapeutics (TCT) 2025 set the tone for a new era in medical technology, emphasizing disruptive innovation as the driving force behind the future of healthcare transformation. Andrew Cleeland, CEO of Fogarty Innovation and a leading global advocate for clinician-led entrepreneurship, urged the medical community to look beyond incremental progress and focus on value based disruption.

“Innovation alone is not enough. It’s about how we create value for patients, physicians, and systems — not just how we make the next shiny device,” said Cleeland, addressing a global audience of clinicians, inn

See Full Page